These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8992915)

  • 21. Neurophysiological evidence for altered sensory function caused by storage of hydroxyethyl starch in cutaneous nerve fibres.
    Ständer S; Evers S; Metze D; Schmelz M
    Br J Dermatol; 2005 May; 152(5):1085-6. PubMed ID: 15888187
    [No Abstract]   [Full Text] [Related]  

  • 22. Hydroxyethyl starch 130/0.4: safe in cardiac surgery?
    Davidson IJ
    Crit Care Med; 2008 May; 36(5):1695-6; author reply 1696. PubMed ID: 18448958
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of spontaneous subdural hematoma and bone marrow depression after hydroxyethyl starch administration.
    Chappell D; Bruchelt W; Schenk W; Jacob M; Hofmann-Kiefer K; Conzen P; Kreimeier U; Rehm M
    J Pediatr; 2008 Oct; 153(4):579-81. PubMed ID: 18847623
    [No Abstract]   [Full Text] [Related]  

  • 24. Acquired type I von Willebrand's disease associated with highly substituted hydroxyethyl starch.
    Jonville-Béra AP; Autret-Leca E; Gruel Y
    N Engl J Med; 2001 Aug; 345(8):622-3. PubMed ID: 11529231
    [No Abstract]   [Full Text] [Related]  

  • 25. Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves.
    Metze D; Reimann S; Szepfalusi Z; Bohle B; Kraft D; Luger TA
    Br J Dermatol; 1997 Apr; 136(4):553-9. PubMed ID: 9155957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hydroxyethylstarches and postoperative renal dysfunction].
    Mion G; Libert N; Cirodde A
    Ann Fr Anesth Reanim; 2010 Jan; 29(1):58; author reply 58-9. PubMed ID: 20071134
    [No Abstract]   [Full Text] [Related]  

  • 27. The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch.
    Shaw AD; Kellum JA
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):497-503. PubMed ID: 23335037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
    Ooi JS; Ramzisham AR; Zamrin MD
    Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk with strict glucose control and hydroxyethyl starch in severe sepsis. Routine intensive care treatments are now questioned].
    Berggren L
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3516-7. PubMed ID: 19133578
    [No Abstract]   [Full Text] [Related]  

  • 30. [How would a volume dose be transported in renal insufficiency?].
    Alscher DM
    Dtsch Med Wochenschr; 2004 Mar; 129(12):646. PubMed ID: 15011136
    [No Abstract]   [Full Text] [Related]  

  • 31. Hydroxyethyl starch and granulocyte transfusions: considerations of utility and toxicity profile for patients and donors.
    Ambruso DR
    Transfusion; 2015 Apr; 55(4):911-8. PubMed ID: 25315227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute kidney injury by hydroxyethyl starch: Can the risks be mitigated?
    Davidson IJ
    Crit Care Med; 2009 Apr; 37(4):1499-501. PubMed ID: 19318837
    [No Abstract]   [Full Text] [Related]  

  • 33. [Is it more necessary to prescribe hydroxyethylstarch?].
    Mimoz O; Capdevila X
    Ann Fr Anesth Reanim; 2009 Jun; 28(6):515-6. PubMed ID: 19481411
    [No Abstract]   [Full Text] [Related]  

  • 34. Comment on reference to maximum dose for starch.
    Bennett-Guerrero E; Gan TJ; Roche AM; Mythen MG
    Anesthesiology; 2010 Mar; 112(3):757-8; author reply 758-60. PubMed ID: 20179520
    [No Abstract]   [Full Text] [Related]  

  • 35. Early and late histamine release induced by albumin, hetastarch and polygeline: some unexpected findings.
    Celik I; Duda D; Stinner B; Kimura K; Gajek H; Lorenz W
    Inflamm Res; 2003 Oct; 52(10):408-16. PubMed ID: 14520516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A new hydroxyethyl starch for volume replacement: Elohes 6%].
    Medel J; Baron JF
    Rev Esp Anestesiol Reanim; 1998 Nov; 45(9):389-96. PubMed ID: 9847657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of hydroxyethylstarch: colloidal confusion or clarity?
    Lang JD; Chaiwat O
    Crit Care Med; 2007 Dec; 35(12):2864-6. PubMed ID: 18043209
    [No Abstract]   [Full Text] [Related]  

  • 38. Hetastarch haemophilia.
    Neparidze N; Kriz N; Ornstein DL
    Haemophilia; 2009 Jul; 15(4):976-9. PubMed ID: 19473419
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
    Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
    Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.